Decline of RSV-specific antibodies during the COVID-19 pandemic
- PMID: 36463892
- PMCID: PMC9714975
- DOI: 10.1016/S1473-3099(22)00763-0
Decline of RSV-specific antibodies during the COVID-19 pandemic
Conflict of interest statement
The study was funded by the Dutch Ministry of Health, Welfare, and Sports. The funder had no role in the generation of the data or writing of the manuscript. ACT received funds from the Respiratory Syncytial Virus Consortium in Europe and Preparing for RSV Immunisation and Surveillance in Europe consortium for grants and travel costs. All other authors declare no competing interests. We thank all study participants, the Dutch Working Group on Clinical Virology from the Dutch Society for Clinical Microbiology, and all participating laboratories for providing the virological data from the weekly laboratory virological report.
Figures

References
-
- Bardsley M, Morbey RA, Hughes HE, et al. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00525-4. published online Sept 2. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical